Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02507583
Title Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

high grade glioma

Therapies

IGF-1R/AS ODN

Age Groups: adult
Covered Countries USA


No variant requirements are available.